Feasibility and Diagnostic Yield of Blind Transrectal Digital Core Biopsy for Prostate Cancer in a Resource Limited Setting: A Cross Sectional Study
Kivu Medical Journal · 21.06.2026 · 4 (1) · 1-8
DOI: 10.64263/kmj.v4i1.84 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kivu Medical Journal, online erschienen am 21.06.2026. Verfasst von Jacques Fadhili Bake und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Introduction: Prostate cancer imposes a significant burden in resource-limited settings where advanced imaging like transrectal ultrasound or MRI is unavailable, necessitating evaluation of simpler biopsy techniques. This study aimed to assess the feasibility, diagnostic yield, safety profile, and prognostic utility of serum PSA in blind transrectal digital-guided core prostate biopsy performed at a low resource setting. The primary research question was whether this technique provides clinically meaningful histopathological confirmation and risk stratification in high-prevalence, late-presentation populations. Matérial and methodsThis prospective cross‑sectional study included 46 consecutive men (mean age 71 years) who underwent blind digital transrectal core biopsy at HEAL Africa Hospital (April 2023–September 2025). Histopathology categorized specimens as benign or malignant. Continuous variables were summarized as mean ± standard deviation, categorical variables as frequencies and percentages. Because PSA values were non‑normally distributed, non‑parametric analyses were applied, including Spearman’s correlation and receiver operating characteristic (ROC) curve analysis to assess PSA discrimination (AUC, optimal cutoff via Youden index). Statistical significance was set at p < 0.05. Results: Adenocarcinoma was confirmed in 69.6% (32/46), with high-grade tumors (Gleason ≥8) in 46.8%. PSA strongly associated with cancer diagnosis (rₛ =0.782, p
Zitieren
APA
Bake, J. F., Omari, M. D., Bangidile, B. K., Barianga, M. M., Kihemba, K., & Akomu, E. M. (2026). Feasibility and Diagnostic Yield of Blind Transrectal Digital Core Biopsy for Prostate Cancer in a Resource Limited Setting: A Cross Sectional Study. Kivu Medical Journal, 4(1), 1-8. https://doi.org/10.64263/kmj.v4i1.84
Vancouver
Bake JF, Omari MD, Bangidile BK, Barianga MM, Kihemba K, Akomu EM. Feasibility and Diagnostic Yield of Blind Transrectal Digital Core Biopsy for Prostate Cancer in a Resource Limited Setting: A Cross Sectional Study. Kivu Medical Journal. 2026;4(1):1-8. doi:10.64263/kmj.v4i1.84
BibTeX
@article{Bake2026,
author = {Bake, Jacques Fadhili and Omari, Mireille Dodo and Bangidile, Benjamin Kabangu and Barianga, Meshack Musubao and Kihemba, Kasereka and Akomu, Eugene Munyantwari},
title = {Feasibility and Diagnostic Yield of Blind Transrectal Digital Core Biopsy for Prostate Cancer in a Resource Limited Setting: A Cross Sectional Study},
journal = {Kivu Medical Journal},
year = {2026},
volume = {4},
number = {1},
pages = {1--8},
doi = {10.64263/kmj.v4i1.84}
}
EUVIMED